Barrington Research Brokers Lift Earnings Estimates for MMSI

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Analysts at Barrington Research boosted their FY2026 earnings per share estimates for Merit Medical Systems in a research note issued to investors on Monday, December 23rd. Barrington Research analyst M. Petusky now forecasts that the medical instruments supplier will post earnings per share of $4.28 for the year, up from their prior estimate of $4.25. Barrington Research has a “Outperform” rating and a $114.00 price objective on the stock. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.36 per share.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.06. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. The company had revenue of $339.85 million during the quarter, compared to analysts’ expectations of $334.60 million. During the same period last year, the business earned $0.75 EPS. Merit Medical Systems’s revenue for the quarter was up 7.8% on a year-over-year basis.

MMSI has been the subject of a number of other research reports. Canaccord Genuity Group raised their target price on Merit Medical Systems from $125.00 to $127.00 and gave the stock a “buy” rating in a research note on Monday, December 9th. StockNews.com cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Needham & Company LLC reiterated a “buy” rating and issued a $109.00 target price on shares of Merit Medical Systems in a research report on Thursday, October 31st. Wells Fargo & Company raised shares of Merit Medical Systems from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $103.00 to $120.00 in a research report on Wednesday, December 11th. Finally, Bank of America upped their price objective on shares of Merit Medical Systems from $92.00 to $103.00 and gave the company a “neutral” rating in a report on Monday, September 16th. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $105.60.

Merit Medical Systems Trading Up 0.4 %

NASDAQ:MMSI opened at $98.44 on Wednesday. The company has a market capitalization of $5.74 billion, a P/E ratio of 48.26, a PEG ratio of 2.55 and a beta of 0.84. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57. Merit Medical Systems has a 12 month low of $70.70 and a 12 month high of $108.07. The firm has a fifty day simple moving average of $100.90 and a 200-day simple moving average of $94.18.

Insiders Place Their Bets

In other Merit Medical Systems news, Director F. Ann Millner sold 12,500 shares of the firm’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.55, for a total value of $1,269,375.00. Following the transaction, the director now directly owns 32,391 shares of the company’s stock, valued at $3,289,306.05. This trade represents a 27.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Raul Jr. Parra sold 29,646 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $98.02, for a total value of $2,905,900.92. Following the completion of the sale, the chief financial officer now owns 16,361 shares of the company’s stock, valued at $1,603,705.22. This trade represents a 64.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of MMSI. USA Financial Formulas acquired a new position in Merit Medical Systems in the 3rd quarter valued at about $59,000. National Bank of Canada FI acquired a new position in Merit Medical Systems during the 2nd quarter worth about $77,000. Anfield Capital Management LLC acquired a new stake in shares of Merit Medical Systems during the second quarter worth about $86,000. Farther Finance Advisors LLC boosted its position in Merit Medical Systems by 32.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 260 shares during the period. Finally, Harvest Fund Management Co. Ltd acquired a new position in Merit Medical Systems during the 3rd quarter worth $120,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.